CME Group Stock Forecast, Price & News

CME Group's stock was trading at $194.6750 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CME stock has decreased by 5.5% and is now trading at $184.04.
View which stocks have been most impacted by COVID-19.

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 3 sell ratings, 8 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View analyst ratings for CME Group or view MarketBeat's top 5 stock picks.

Wall Street analysts have given CME Group a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CME Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

144 employees have rated CME Group CEO Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among CME Group's employees.

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021.
View our earnings forecast for CME Group.

CME Group will be holding an earnings conference call on Wednesday, February 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

CME Group Inc. (NASDAQ:CME) released its quarterly earnings results on Wednesday, October, 28th. The financial services provider reported $1.38 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.41 by $0.03. The financial services provider earned $1.08 billion during the quarter, compared to analysts' expectations of $1.09 billion. CME Group had a trailing twelve-month return on equity of 9.22% and a net margin of 43.68%. During the same quarter last year, the business posted $1.90 earnings per share.
View CME Group's earnings history.

CME Group declared a None dividend on Thursday, December 10th. Investors of record on Monday, December 28th will be paid a dividend of $2.50 per share on Wednesday, January 13th. The ex-dividend date is Thursday, December 24th.
View CME Group's dividend history.

CME Group pays an annual dividend of $3.40 per share and currently has a dividend yield of 1.85%. The dividend payout ratio of CME Group is 50.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME Group will have a dividend payout ratio of 51.44% next year. This indicates that CME Group will be able to sustain or increase its dividend.
View CME Group's dividend history.

16 analysts have issued 12-month target prices for CME Group's stock. Their forecasts range from $135.00 to $225.00. On average, they anticipate CME Group's share price to reach $187.00 in the next year. This suggests a possible upside of 1.6% from the stock's current price.
View analysts' price targets for CME Group or view Wall Street analyst' top-rated stocks.

Some companies that are related to CME Group include Intercontinental Exchange (ICE), Moody's (MCO), MSCI (MSCI), Interactive Brokers Group (IBKR), Nasdaq (NDAQ), MarketAxess (MKTX), Cboe Global Markets (CBOE), Arrow Financial (AROW), California First National Bancorp (CFNB) and Marlin Business Services (MRLN).
View all of CME's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), The Walt Disney (DIS), Visa (V), Netflix (NFLX), The Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group's stock is owned by many different institutional and retail investors. Top institutional shareholders include Sarasin & Partners LLP (0.50%), Pendal Group Limited (0.26%), Waverton Investment Management Ltd (0.12%), Manning & Napier Group LLC (0.07%), State of Alaska Department of Revenue (0.03%) and Windward Capital Management Co. CA (0.02%). Company insiders that own CME Group stock include Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including Parkside Investments LLC, Windward Capital Management Co. CA, Manning & Napier Group LLC, Kestra Private Wealth Services LLC, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH, Pacer Advisors Inc., Mission Wealth Management LP, and City Holding Co.. Company insiders that have sold CME Group company stock in the last year include Charles P Carey, Daniel R Glickman, Dennis Suskind, Hilda Harris Piell, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Ken Vroman, Martin J Gepsman, and Timothy S Bitsberger.
View insider buying and selling activity for CME Group or view top insider-selling stocks.

CME stock was acquired by a variety of institutional investors in the last quarter, including Waverton Investment Management Ltd, Sarasin & Partners LLP, Pendal Group Limited, Viking Fund Management LLC, Cullinan Associates Inc., Gofen & Glossberg LLC IL, Tuttle Tactical Management, and IFM Investors Pty Ltd.
View insider buying and selling activity for CME Group or or view top insider-buying stocks.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CME stock can currently be purchased for approximately $184.04.

CME Group has a market capitalization of $66.07 billion and generates $4.87 billion in revenue each year. The financial services provider earns $2.12 billion in net income (profit) each year or $6.80 on an earnings per share basis. CME Group employs 4,360 workers across the globe.

The official website for CME Group is www.cmegroup.com.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]